{{Rsnum
|rsid=243866
|Gene=MMP2
|Chromosome=16
|position=55477625
|Orientation=plus
|GMAF=0.1552
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=MMP2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 6.2 | 36.3 | 57.5
| HCB | 0.7 | 16.8 | 82.5
| JPT | 0.9 | 10.6 | 88.5
| YRI | 0.0 | 5.4 | 94.6
| ASW | 0.0 | 7.0 | 93.0
| CHB | 0.7 | 16.8 | 82.5
| CHD | 1.8 | 16.5 | 81.7
| GIH | 1.0 | 22.8 | 76.2
| LWK | 0.0 | 0.0 | 0.0
| MEX | 1.7 | 36.2 | 62.1
| MKK | 0.0 | 0.6 | 99.4
| TSI | 7.8 | 37.3 | 54.9
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19332048
|Title=Polymorphisms of MMP-2 Gene are Associated with Systolic Heart Failure Prognosis
}}

{{PMID Auto
|PMID=20808730
|Title=Role of functional single nucleotide polymorphisms of MMP1, MMP2, and MMP9 in open angle glaucomas
|OA=1
}}

{{PMID Auto
|PMID=19295411
|Title=Polymorphisms of MMP-2 gene are associated with systolic heart failure risk in Han Chinese.
}}

{{PMID Auto
|PMID=19454611
|Title=Matrix metalloproteinase-2 polymorphisms and breast cancer susceptibility.
|OA=1
}}

{{PMID Auto
|PMID=20222942
|Title=Variants of the Matrix Metalloproteinase-2 but not the Matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke.
|OA=1
}}

{{PMID Auto
|PMID=23801889
|Title=Genetic Polymorphisms of Matrix Metalloproteinases and Clinical Outcomes in Colorectal Cancer Patients
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | NatGeo2}}